Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 365

Will value stocks benefit from the market's inflection point?

Two dominant investment styles are value versus growth. Value investors look for undervalued stocks while growth investors prefer companies with strong earnings growth potential. While value investing has outperformed over the long term, its underperformance in recent years, particularly in the recent selloff, has caused many to question when the promised value recovery will occur.

To shed some light on this, it is helpful to understand when value has outperformed in the past and the market conditions that led to this.

Where are the value stocks?

Value stocks are typically found in the more cyclical parts of the market such as the Financials, Resources and Consumer Discretionary sectors. These stocks are more sensitive to broader economic conditions, compared to defensive sectors such as Healthcare, Utilities, and Consumer Staples.

Value stocks tend to outperform when economic conditions are improving. In such an environment, the earnings growth outlook from the cyclical parts of the market improves relative to defensive sectors. This drives a rotation out of defensives and into cyclicals, leading to a period of relative outperformance by value.

The second point is that value stocks typically perform better in a rising interest rate environment. This is the result of two factors.

Firstly, rising interest rates usually correspond with improving economic conditions, which as mentioned above, generally favours value.

Secondly, rising interest rates increase the discount rate applied to future earnings and in general, ‘growthier’ stocks are more impacted as a greater proportion of their valuation is based on long-term future earnings. Therefore, a higher discount rate has a bigger impact on the valuation of growth stocks than it does on value stocks, which are more driven by nearer-term earnings and dividends.

In light of this, it’s easy to see why the past few years have been difficult for value investing, as global economic growth has been patchy, and we have been in a lower for longer interest rate environment.

The chart below shows how value stocks do better coming out of recessions, but how much growth has won in recent years.

This environment has been very favourable to stocks offering perceived defensive characteristics, such as infrastructure, or strong organic growth, such as healthcare. Valuations of these types of stocks have pushed up to high levels, both in absolute terms and versus their own historical valuation metrics. At the same time, value stocks have lagged and the valuation gap between cheap and expensive stocks is currently at record levels.

Value fighting back

In the second half of 2019, it appeared there was some light at the end of the tunnel. Global growth was starting to pick up, led by the US, as trade tensions eased and the UK election saw a resolution of the Brexit impasse. Bond yields were starting to tick up and value began logging several months of outperformance.

However, the COVID-19 pandemic put a halt to this, seeing economic growth collapse, interest rates slashed, and investors taking flight to ‘safe haven’ stocks. These factors predictably saw value underperform during the sell-off.

Tellingly, however, since its bottom in late March, the market has rallied sharply, led by cyclicals, and value outperformed strongly in April and May. Over this period, the Perennial Value Australian Shares Trust (PVAST) delivered a return of 19.9% versus the 14.1% return of the benchmark S&P/ASX 300 index. We believe the fund’s ‘true to label’ value approach was an important driver of outperformance during the rally.

The key point is that value tends to outperform not when a crisis is unfolding, but rather, in its aftermath. This is when either the bubbles of euphoria that had been driving the market up may have burst, or the fears that had driven the market down have been realised and dealt with. At this point, investors form the conclusion that the economy will recover, and life will go on. They then seek out solid, reliable, reasonably priced businesses to invest in – in other words, they look to value stocks.

These periods have also shown that style rotation, when it occurs, can happen sharply. When valuation dispersion reaches extreme levels, such as we are seeing today, something usually gives and mean reversion kicks in, resulting in a period of strong outperformance for value investing.

If current trends continue, then the impacts from COVID-19 may be less severe than feared and economies may bounce back. If this is the case, we will have an improving economic outlook, interest rates already at extremely low levels and unlikely to go any lower, and valuation dispersion at record levels. In effect, all the preconditions would be in place for a rotation to value.

Not only does maintaining an exposure to value alongside other styles provide a form of diversification in a portfolio, but after a long period in the wilderness, the tide may be turning in value’s favour.

 

Stephen Bruce is a Director of Perennial Value Management and Portfolio Manager of the Perennial Value Australian Shares Trust. This article is general information and does not consider the circumstances of any investor.

 

RELATED ARTICLES

Inflation: friend or foe of Value stocks in 2022?

Will the drought break for value stocks continue?

After 30 years of investing, I prefer to skip this party

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.